ArticlePharmaceuticals (Basel, Switzerland)2026
Analytical and Clinical Validation of Action PharmaKitDx: A Comprehensive NGS Panel for the Identification of Pharmacogenetic Variants in Diverse Populations.
Luis Ramudo-Cela, Marta Izquierdo-García, María Dolores-Sequedo, Vicente Cubells-Perez, Sara Bernal, Pau Riera, Adriana Lasa, Laura Torres-Juan, Victor José Asensio, Iciar Martínez-López and 5 more
Abstract read
In one paragraphArticle in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
15 authors.
Luis Ramudo-CelaHealth in Code, 46024 Valencia, Spain.
Marta Izquierdo-GarcíaHealth in Code, 46024 Valencia, Spain.
María Dolores-SequedoHealth in Code, 46024 Valencia, Spain.
Vicente Cubells-PerezHealth in Code, 46024 Valencia, Spain.
Laura Torres-JuanGenomics of Health Research Group, Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.ORCID 0000-0002-8739-6081 Victor José AsensioGenomics of Health Research Group, Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.
Iciar Martínez-LópezGenomics of Health Research Group, Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.
Antonia Obrador de HeviaGenomics of Health Research Group, Health Research Institute of the Balearic Islands (IdISBa), 07120 Palma, Spain.ORCID 0000-0002-4630-2077 Matías MorínGenetics Service, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Hospital Ramón y Cajal, 28034 Madrid, Spain.ORCID 0000-0002-7985-592X Miguel Ángel Moreno-PelayoGenetics Service, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Hospital Ramón y Cajal, 28034 Madrid, Spain.ORCID 0000-0003-3839-5098 Greta Carmona-AntoñanzasHealth in Code, 46024 Valencia, Spain.
Javier Porta PelayoHealth in Code, 46024 Valencia, Spain.
Funding
Agència Valenciana de la Innovació INNCP1/2022/4
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
analytical validationclinical pharmacogeneticsclinical validationcopy number variationcytochrome P-450 enzyme systemdrug metabolismnext-generation sequencingpharmacogenomicsprecision medicine
Identifiers
PMID42075824
PMCPMC13119443
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390